Get the Stockscreener App
2.33
0.43%
0.01
After Hours:
2.34
0.010
+0.43%
Cerus Corp stock is traded at $2.33, with a volume of 947.88K.
It is up +0.43% in the last 24 hours and up +11.48% over the past month.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
See More
Previous Close:
$2.32
Open:
$2.28
24h Volume:
947.88K
Relative Volume:
0.65
Market Cap:
$447.56M
Revenue:
$156.37M
Net Income/Loss:
$-37.49M
P/E Ratio:
-11.10
EPS:
-0.21
Net Cash Flow:
$-47.77M
1W Performance:
-6.43%
1M Performance:
+11.48%
6M Performance:
+77.86%
1Y Performance:
+17.68%
1-Day Range:
$2.245
$2.36
1-Week Range:
$2.245
$2.54
52-Week Range:
$1.12
$2.955
Cerus Corp Stock (CERS) Company Profile
Name
Cerus Corp
Sector
Industry
Phone
(925) 288-6000
Address
1220 CONCORD AVENUE, CONCORD, CA
Compare CERS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
2.33 | 445.64M | 156.37M | -37.49M | -47.77M | -0.21 |
|
ABT
Abbott Laboratories
|
109.30 | 184.48B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
369.56 | 135.49B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
BSX
Boston Scientific Corp
|
93.53 | 136.93B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
102.96 | 129.48B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
81.36 | 47.29B | 5.88B | 1.34B | 799.60M | 2.3489 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-12-24 | Initiated | Craig Hallum | Buy |
| Jan-20-23 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-17-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-08-20 | Resumed | BTIG Research | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| Feb-26-20 | Initiated | BTIG Research | Buy |
| Nov-13-19 | Upgrade | BTIG Research | Neutral → Buy |
| Aug-28-19 | Initiated | Stifel | Buy |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Dec-08-17 | Resumed | BTIG Research | Neutral |
| Jul-07-16 | Resumed | Cantor Fitzgerald | Buy |
| Dec-17-15 | Downgrade | Wedbush | Outperform → Neutral |
| May-02-14 | Reiterated | MLV & Co | Buy |
| Apr-24-13 | Reiterated | Cantor Fitzgerald | Buy |
| Mar-15-13 | Reiterated | MLV & Co | Buy |
| Apr-17-12 | Initiated | Cantor Fitzgerald | Buy |
| Feb-29-12 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-10-11 | Reiterated | MLV & Co | Buy |
| Jun-03-11 | Initiated | Wedbush | Outperform |
| Mar-04-11 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-09-10 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-26-09 | Upgrade | Avondale | Mkt Perform → Mkt Outperform |
View All
Cerus Corp Stock (CERS) Latest News
Cerus director Timothy L. Moore to step down after 2026 annual meeting - Investing.com
New German trial tests safer platelets for cancer patients - Stock Titan
DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus’ INTERCEPT™ Blood System in Routine Clinical Practice - Yahoo Finance
Sumitomo Mitsui Trust Group Inc. Lowers Stock Holdings in Cerus Corporation $CERS - MarketBeat
Is Cerus Corporation being accumulated by smart money2025 Volume Leaders & High Accuracy Investment Signals - baoquankhu1.vn
Cerus (NASDAQ:CERS) Sets New 52-Week HighWhat's Next? - MarketBeat
Analysts Offer Insights on Healthcare Companies: Cerus (CERS) and Kura Oncology (KURA) - The Globe and Mail
TD Cowen reiterates Buy rating on Cerus stock after strong Q4 results - Investing.com
CERS Projects Revenue Growth in 2026 - GuruFocus
Cerus (CERS) Reports Significant Global Expansion of INTERCEPT B - GuruFocus
Cerus (CERS) Reports Strong Revenue Growth Driven by INTERCEPT F - GuruFocus
Cerus expects 14% jump in 2025 topline, guides 2026 (CERS:NASDAQ) - Seeking Alpha
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook - Yahoo Finance
Revenue Check: Why Cerus Corporation stock is recommended by analysts2025 Volume Leaders & Risk Controlled Daily Trade Plans - Улправда
Cerus (NASDAQ:CERS) Shares Pass Above 200-Day Moving AverageShould You Sell? - MarketBeat
Cerus (NASDAQ:CERS) Shares Pass Above 200-Day Moving Average – Should You Sell? - Defense World
2026 world cup canada semifinals top scorers low block match prediction analysisMarket Risk Summary & AI Driven Price Forecasts - ulpravda.ru
What hedge fund activity signals for CNVS stockWeekly Gains Report & Safe Entry Zone Identification - ulpravda.ru
What insider trading reveals about Cerus Corporation stockMarket Volume Report & Verified Chart Pattern Trade Signals - Улправда
2026 world cup team news tips: Why Cerus Corporation stock is recommended by analysts2026 world cup usa national team quarterfinals young talents set piece tactics knockout prediction guide - ulpravda.ru
Cerus (NASDAQ:CERS) Stock Price Passes Above 200 Day Moving Average – Should You Sell? - Defense World
Cerus (NASDAQ:CERS) Stock Price Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
TD Cowen Sees Compelling Long-Term Value in Cerus Corporation (CERS) - Finviz
Assenagon Asset Management S.A. Purchases 358,548 Shares of Cerus Corporation $CERS - Defense World
Analysts’ Top Healthcare Picks: Cerus (CERS), Entera Bio (ENTX) - The Globe and Mail
Financial Analysis: Cerus (NASDAQ:CERS) vs. PURE Bioscience (OTCMKTS:PURE) - Defense World
Cerus (CERS): Strong Growth Potential and Increased Valuation - GuruFocus
Can Cerus Corporation (CU2) stock test all time highs2025 Earnings Impact & AI Based Buy/Sell Signal Reports - Улправда
Can Cerus Corporation stock resist market sell offsJuly 2025 Market Mood & Weekly Consistent Profit Watchlists - Улправда
Cerus announces group purchasing pact with Blood Centers of America - MSN
Will Cerus Corporation stock beat EPS estimatesJuly 2025 Technicals & Short-Term Swing Trade Alerts - Улправда
Why Cerus Corporation stock is recommended by analystsJuly 2025 Breakouts & AI Powered Buy/Sell Recommendations - Улправда
Cerus Corporation (NASDAQ:CERS) Stock Catapults 33% Though Its Price And Business Still Lag The Industry - 富途牛牛
Cerus (NASDAQ:CERS) Share Price Crosses Above 200-Day Moving Average – What’s Next? - Defense World
Cerus (NASDAQ:CERS) Share Price Crosses Above 200-Day Moving AverageWhat's Next? - MarketBeat
Cerus Shares Surge on Strategic Deal and Financial Momentum - AD HOC NEWS
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
After-Hours Gainers: Biotech Stocks Climb On Data Anticipation And Momentum Buying - RTTNews
Cerus Corporation CU2 Stock Analysis and ForecastEvening Star Patterns & Exceptional Capital Trading - earlytimes.in
Cerus signs purchasing agreement with Blood Centers of America By Investing.com - Investing.com Nigeria
Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America - Bakersfield.com
Cerus signs purchasing agreement with Blood Centers of America - Investing.com
Cerus (NASDAQ:CERS) Stock Crosses Above 200 Day Moving Average – Should You Sell? - Defense World
Promising Penny Stocks To Watch In December 2025 - simplywall.st
Perhaps timely catching Cerus Corp (CERS) would be a good idea - setenews.com
Cerus (NASDAQ:CERS) Stock Crosses Above 200 Day Moving AverageShould You Sell? - MarketBeat
Cerus Corp (NASDAQ:CERS) Nasdaq Composite Global Safety Systems - Kalkine Media
Why Cerus Corporation (CU2) stock stays resilientJuly 2025 Spike Watch & Real-Time Stock Entry Alerts - Newser
Published on: 2025-12-04 13:43:09 - Newser
How Cerus Corporation (CU2) stock trades pre earningsWeekly Trade Recap & Risk Controlled Swing Trade Alerts - Newser
Cerus Corporation (NASDAQ:CERS) Stock Catapults 31% Though Its Price And Business Still Lag The Industry - simplywall.st
Cerus Corp Stock (CERS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.28%
1.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):